Ikab Securities and Investment Ltd
BSE:514238
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ikab Securities and Investment Ltd
BSE:514238
|
IN |
|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
JP |
|
N
|
Novo Resources Corp
SWB:1NO
|
CA |
|
P
|
PXP Energy Corp
XPHS:PXP
|
PH |
Cash Flow Statement
Cash Flow Statement
Ikab Securities and Investment Ltd
| Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||
| Net Income |
218
|
333
|
288
|
275
|
131
|
106
|
|
| Depreciation & Amortization |
0
|
0
|
1
|
3
|
4
|
3
|
|
| Other Non-Cash Items |
43
|
122
|
73
|
10
|
76
|
37
|
|
| Cash Taxes Paid |
55
|
80
|
75
|
61
|
54
|
66
|
|
| Cash Interest Paid |
33
|
33
|
87
|
87
|
7
|
7
|
|
| Change in Working Capital |
(2 853)
|
(940)
|
2 219
|
(191)
|
121
|
569
|
|
| Cash from Operating Activities |
(2 592)
N/A
|
(485)
+81%
|
2 581
N/A
|
97
-96%
|
332
+244%
|
715
+115%
|
|
| Investing Cash Flow | |||||||
| Capital Expenditures |
0
|
(2)
|
(12)
|
(10)
|
(0)
|
(0)
|
|
| Other Items |
139
|
(127)
|
(83)
|
282
|
(627)
|
(525)
|
|
| Cash from Investing Activities |
139
N/A
|
(130)
N/A
|
(95)
+26%
|
272
N/A
|
(627)
N/A
|
(525)
+16%
|
|
| Financing Cash Flow | |||||||
| Net Issuance of Common Stock |
0
|
400
|
400
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
2 488
|
221
|
(2 488)
|
(292)
|
0
|
0
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
(4)
|
(4)
|
0
|
|
| Other |
(33)
|
(33)
|
(87)
|
(87)
|
(7)
|
(7)
|
|
| Cash from Financing Activities |
2 456
N/A
|
588
-76%
|
(2 176)
N/A
|
(383)
+82%
|
(11)
+97%
|
(186)
-1 551%
|
|
| Change in Cash | |||||||
| Net Change in Cash |
3
N/A
|
(27)
N/A
|
309
N/A
|
(15)
N/A
|
(307)
-1 894%
|
3
N/A
|
|
| Free Cash Flow | |||||||
| Free Cash Flow |
(2 592)
N/A
|
(487)
+81%
|
2 568
N/A
|
86
-97%
|
331
+284%
|
714
+116%
|
|